Their essay was prompted by a 2008 meta-analysis of Boehringer Ingelheim's Spiriva HandiHaler that is used to treat chronic obstructive pulmonary disease, or COPD.
In 2010, Boehringer Ingelheim posted net sales of about 12.6 billion euro while spending almost 24% of net sales in its largest business segment Prescription Medicines on research and development.
3
勃林格殷格翰集团是世界上最大的制药公司之一。
Boehringer Ingelheim is one of the largest pharmaceutical companies in the world.